Showing results (171-180 of 187) with videos related to
Sort By:
Pageof 19
International Journal of Clinical Oncology|July 21, 2022
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and RectumTakahiko Ito, Atsuo Takashima, Kentaro Yamazaki, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 2, 2020
Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trialKazumasa Fujitani, Kohei Shitara, Atsuo Takashima, et al.International Journal of Clinical Oncology|March 4, 2026
Comparison of first-line cetuximab and panitumumab plus doublet chemotherapies for left-sided colorectal cancer: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and RectumRyosuke Kawagoe, Toshikazu Moriwaki, Kentaro Yamazaki, et al.International Journal of Clinical Oncology|August 28, 2024
Real-world outcomes of FOLFOXIRI plus bevacizumab in patients with metastatic colorectal cancer: the JSCCR-TRIPON studyYoshiyuki Yamamoto, Hiroki Yukami, Tatsuro Yamaguchi, et al.The Oncologist|September 13, 2017
Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational StudyToshikazu Moriwaki, Shota Fukuoka, Hiroya Taniguchi, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 2, 2018
Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trialAtsuo Takashima, Kohei Shitara, Kazumasa Fujitani, et al.Frontiers in Oncology|July 2, 2021
Clinical Impact of Primary Tumor Location in Metastatic Colorectal Cancer Patients Under Later-Line Regorafenib or Trifluridine/Tipiracil TreatmentHiromichi Nakajima, Shota Fukuoka, Toshiki Masuishi, et al.Journal of Hematology & Oncology|February 10, 2026
Implementing generative artificial intelligence in precision oncology: safety, governance, and significanceRyuji Hamamoto, Takafumi Koyama, Satoshi Takahashi, et al.Gynecologic Oncology|February 10, 2015
Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A)Tomoyasu Kato, Atsuo Takashima, Takahiro Kasamatsu, et al.Clinical Colorectal Cancer|August 29, 2018
Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal CancerKenji Tsuchihashi, Mamoru Ito, Toshikazu Moriwaki, et al.Pageof 19